endolysin has been researched along with chitosan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chhibber, S; Dube, T; Gondil, VS; Harjai, K; Panda, JJ; Yennamalli, RM | 1 |
| Chhibber, S; Harjai, K; Kaur, J; Kour, A; Panda, JJ | 1 |
| Aguilar, MR; Caro-León, FJ; Doñoro, C; García, P; García-Fernández, L; Nakal, A; Ruiz, S; San Román, J; Sanz, J; Vázquez, R; Vázquez-Lasa, B | 1 |
| Chang, Y; Lu, X; Qi, Q; Yuan, Y; Zhang, Q; Zhang, S | 1 |
4 other study(ies) available for endolysin and chitosan
| Article | Year |
|---|---|
Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections.
Topics: A549 Cells; Administration, Intranasal; Animals; Bacteriophages; Biological Availability; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Drug Liberation; Endopeptidases; Feasibility Studies; Half-Life; Humans; Male; Materials Testing; Mice; Molecular Docking Simulation; Nanoparticles; Pneumonia, Pneumococcal; Recombinant Proteins; Streptococcus pneumoniae; Viral Proteins | 2020 |
Exploring Endolysin-Loaded Alginate-Chitosan Nanoparticles as Future Remedy for Staphylococcal Infections.
Topics: Alginates; Animals; Cell Line; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Delivery Systems; Endopeptidases; Forecasting; Humans; Mice; Nanoparticles; Particle Size; Staphylococcal Infections; Staphylococcus aureus | 2020 |
DEAE-chitosan nanoparticles as a pneumococcus-biomimetic material for the development of antipneumococcal therapeutics.
Topics: A549 Cells; Anti-Bacterial Agents; Bacterial Proteins; Biomimetic Materials; Chitosan; Drug Carriers; Drug Liberation; Endopeptidases; Humans; Nanoparticles; Streptococcus pneumoniae | 2021 |
Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Chitosan; Edetic Acid; Endopeptidases; Escherichia coli; Gram-Negative Bacteria; Rabbits; Salmonella | 2022 |